Lipid-lowering Agent Market Report

Global and Region Lipid-lowering Agent Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：221
  • REPORT CODE：GMM1012443
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Lipid-lowering Agent market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Lipid-lowering Agentmarket, defines the market attractiveness level of Lipid-lowering Agent market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Lipid-lowering Agent industry, describes the types of Lipid-lowering Agent market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lipid-lowering Agent market and the development prospects and opportunities of Lipid-lowering Agent industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lipid-lowering Agent market in Chapter 13.

    By Player:

    • Torrent Pharmaceuticals

    • GlaxoSmithKline

    • SUN Pharma

    • Cerenis Therapeutics

    • HanAll BioPharma

    • Pfizer

    • Abbvie

    • Teva

    • Novartis

    • JX Pharmaceuticals

    • Amgen

    • Merck

    • Abbott

    • AstraZeneca

    • Aurobindo Pharma

    By Type:

    • Niaci

    • Acipimox

    • Fibrates

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Lipid-lowering Agent Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Lipid-lowering Agent Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Lipid-lowering Agent Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Lipid-lowering Agent Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Lipid-lowering Agent Market Analysis and Outlook to 2022

    • 7.1 Global Lipid-lowering Agent Consumption (2017-2022)

    • 7.2 United States Lipid-lowering Agent Consumption (2017-2022)

    • 7.3 Europe Lipid-lowering Agent Consumption (2017-2022)

    • 7.4 China Lipid-lowering Agent Consumption (2017-2022)

    • 7.5 Japan Lipid-lowering Agent Consumption (2017-2022)

    • 7.6 India Lipid-lowering Agent Consumption (2017-2022)

    • 7.7 South Korea Lipid-lowering Agent Consumption (2017-2022)

    8 Region and Country-wise Lipid-lowering Agent Market Analysis and Outlook to 2028

    • 8.1 Global Lipid-lowering Agent Consumption Forecast (2022-2028)

    • 8.2 United States Lipid-lowering Agent Consumption Forecast (2022-2028)

    • 8.3 Europe Lipid-lowering Agent Consumption Forecast (2022-2028)

    • 8.4 China Lipid-lowering Agent Consumption Forecast (2022-2028)

    • 8.5 Japan Lipid-lowering Agent Consumption Forecast (2022-2028)

    • 8.6 India Lipid-lowering Agent Consumption Forecast (2022-2028)

    • 8.7 South Korea Lipid-lowering Agent Consumption Forecast (2022-2028)

    9 Global Lipid-lowering Agent Market Outlook by Types and Applications to 2022

    • 9.1 Global Lipid-lowering Agent Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Niaci Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Acipimox Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Fibrates Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Lipid-lowering Agent Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Lipid-lowering Agent Market Outlook by Types and Applications to 2028

    • 10.1 Global Lipid-lowering Agent Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Niaci Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Acipimox Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Fibrates Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Lipid-lowering Agent Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Lipid-lowering Agent Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Lipid-lowering Agent Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Lipid-lowering Agent Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Lipid-lowering Agent Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Lipid-lowering Agent Market Competitive Analysis

    • 14.1 Torrent Pharmaceuticals

      • 14.1.1 Torrent Pharmaceuticals Company Details

      • 14.1.2 Torrent Pharmaceuticals Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Torrent Pharmaceuticals Lipid-lowering Agent Product and Service

    • 14.2 GlaxoSmithKline

      • 14.2.1 GlaxoSmithKline Company Details

      • 14.2.2 GlaxoSmithKline Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GlaxoSmithKline Lipid-lowering Agent Product and Service

    • 14.3 SUN Pharma

      • 14.3.1 SUN Pharma Company Details

      • 14.3.2 SUN Pharma Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 SUN Pharma Lipid-lowering Agent Product and Service

    • 14.4 Cerenis Therapeutics

      • 14.4.1 Cerenis Therapeutics Company Details

      • 14.4.2 Cerenis Therapeutics Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Cerenis Therapeutics Lipid-lowering Agent Product and Service

    • 14.5 HanAll BioPharma

      • 14.5.1 HanAll BioPharma Company Details

      • 14.5.2 HanAll BioPharma Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 HanAll BioPharma Lipid-lowering Agent Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Lipid-lowering Agent Product and Service

    • 14.7 Abbvie

      • 14.7.1 Abbvie Company Details

      • 14.7.2 Abbvie Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Abbvie Lipid-lowering Agent Product and Service

    • 14.8 Teva

      • 14.8.1 Teva Company Details

      • 14.8.2 Teva Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Teva Lipid-lowering Agent Product and Service

    • 14.9 Novartis

      • 14.9.1 Novartis Company Details

      • 14.9.2 Novartis Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis Lipid-lowering Agent Product and Service

    • 14.10 JX Pharmaceuticals

      • 14.10.1 JX Pharmaceuticals Company Details

      • 14.10.2 JX Pharmaceuticals Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 JX Pharmaceuticals Lipid-lowering Agent Product and Service

    • 14.11 Amgen

      • 14.11.1 Amgen Company Details

      • 14.11.2 Amgen Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Amgen Lipid-lowering Agent Product and Service

    • 14.12 Merck

      • 14.12.1 Merck Company Details

      • 14.12.2 Merck Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Merck Lipid-lowering Agent Product and Service

    • 14.13 Abbott

      • 14.13.1 Abbott Company Details

      • 14.13.2 Abbott Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Abbott Lipid-lowering Agent Product and Service

    • 14.14 AstraZeneca

      • 14.14.1 AstraZeneca Company Details

      • 14.14.2 AstraZeneca Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 AstraZeneca Lipid-lowering Agent Product and Service

    • 14.15 Aurobindo Pharma

      • 14.15.1 Aurobindo Pharma Company Details

      • 14.15.2 Aurobindo Pharma Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Aurobindo Pharma Lipid-lowering Agent Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Lipid-lowering Agent

    • Figure Lipid-lowering Agent Picture

    • Table Global Lipid-lowering Agent Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lipid-lowering Agent Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lipid-lowering Agent Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Lipid-lowering Agent Consumption by Country (2017-2022)

    • Figure United States Lipid-lowering Agent Consumption and Growth Rate (2017-2022)

    • Table Europe Lipid-lowering Agent Consumption and Growth Rate (2017-2022)

    • Figure China Lipid-lowering Agent Consumption and Growth Rate (2017-2022)

    • Figure Japan Lipid-lowering Agent Consumption and Growth Rate (2017-2022)

    • Figure India Lipid-lowering Agent Consumption and Growth Rate (2017-2022)

    • Figure South Korea Lipid-lowering Agent Consumption and Growth Rate (2017-2022)

    • Figure Global Lipid-lowering Agent Consumption Forecast by Country (2022-2028)

    • Figure United States Lipid-lowering Agent Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Lipid-lowering Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Lipid-lowering Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Lipid-lowering Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Lipid-lowering Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Lipid-lowering Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Niaci Consumption and Growth Rate (2017-2022)

    • Figure Global Acipimox Consumption and Growth Rate (2017-2022)

    • Figure Global Fibrates Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Niaci Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acipimox Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fibrates Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Lipid-lowering Agent Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Lipid-lowering Agent Export by Region (Top 5 Countries) (2017-2028)

    • Table Torrent Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Torrent Pharmaceuticals Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Torrent Pharmaceuticals Lipid-lowering Agent Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Lipid-lowering Agent Product and Service

    • Table SUN Pharma (Foundation Year, Company Profile and etc.)

    • Table SUN Pharma Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table SUN Pharma Lipid-lowering Agent Product and Service

    • Table Cerenis Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Cerenis Therapeutics Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cerenis Therapeutics Lipid-lowering Agent Product and Service

    • Table HanAll BioPharma (Foundation Year, Company Profile and etc.)

    • Table HanAll BioPharma Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table HanAll BioPharma Lipid-lowering Agent Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Lipid-lowering Agent Product and Service

    • Table Abbvie (Foundation Year, Company Profile and etc.)

    • Table Abbvie Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Lipid-lowering Agent Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Lipid-lowering Agent Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Lipid-lowering Agent Product and Service

    • Table JX Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table JX Pharmaceuticals Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table JX Pharmaceuticals Lipid-lowering Agent Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Lipid-lowering Agent Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Lipid-lowering Agent Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Lipid-lowering Agent Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Lipid-lowering Agent Product and Service

    • Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)

    • Table Aurobindo Pharma Lipid-lowering Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma Lipid-lowering Agent Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US